NEORAL

This brand name is authorized in Australia, Canada, Germany, France, Ireland, Japan, Netherlands, New Zealand, United Kingdom, United States

Active ingredients

The drug NEORAL contains one active pharmaceutical ingredient (API):

1 Ciclosporin UNII 83HN0GTJ6D - CYCLOSPORINE

Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect. Read about Ciclosporin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEORAL Oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AD01	Ciclosporin	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5632K, 5633L, 5634M, 5635N, 5636P, 6125J, 6232B, 6352H, 6353J, 6354K, 8657P, 8658Q, 8659R, 8660T, 8661W
Country: CA	Health Products and Food Branch	Identifier(s): 02150662, 02150670, 02150689, 02150697, 02237671
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 12669984, 17175181
Country: FR	Base de données publique des médicaments	Identifier(s): 61857901, 62758831, 63094408, 63107460, 64620722, 65272941, 65922428, 65981679, 67194943
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143441, 143448, 143457, 143465, 23547, 23549, 23551, 34906, 373459, 373462, 373465, 53654
Country: IE	Health Products Regulatory Authority	Identifier(s): 88100, 88101, 88102, 88103
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999004M3021, 3999004M4028, 3999004M5024, 3999004S2032
Country: NL	Z-Index G-Standaard	Identifier(s): 14084457
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 40827, 40835, 40843
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3910, 3911, 3912, 3913, 3914
Country: US	FDA, National Drug Code	Identifier(s): 0078-0246, 0078-0248, 0078-0274